Directing alternative splicing to conquer disease
LinkedIn
RSS
AMPA GluA1-flip targeted oligonucleotide therapy paper published in PLOS One Journal
LifeSplice Pharma co-founders featured in local top entrepreneur list
NIH Grant Awarded ($700 K) to Develop Drug to Treat Dravet Syndrome
NIH P2-SBIR Grant Awarded ($3 Million) for Safety Studies of ALS Drug LSP-GR1
Home
News
Investors & Partners
Investor Data
Platform Technology
SMO Advantages
Product Pipeline
Managers
Contact
Dr. Heiman-Patterson New SAB Member
Dr. Terry Heiman-Patterson joins the LifeSplice Scientific Advisory Board